Stoke Therapeutics (STOK) News Today $11.35 -0.28 (-2.41%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock STOK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives Average Rating of "Buy" from AnalystsJune 30 at 2:29 AM | marketbeat.comSTOK Stoke Therapeutics, Inc. - Seeking AlphaJune 29 at 9:44 AM | seekingalpha.comAnalysts Are Bullish on These Healthcare Stocks: Apogee Therapeutics (APGE), Legend Biotech (LEGN)June 28 at 3:13 PM | theglobeandmail.comStoke-on-Trent bungalow could be turned into children's homeJune 28 at 10:12 AM | msn.comStoke City confirm new coach appointment as pre-season startsJune 27, 2025 | msn.comStoke Therapeutics (NASDAQ:STOK) Trading Down 3.5% - Here's WhyJune 26, 2025 | marketbeat.comStoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 17, 2025 | businesswire.comSTOK FY2025 EPS Forecast Lowered by Cantor FitzgeraldJune 16, 2025 | marketbeat.comStoke Therapeutics: Impressive Pipeline And Big BackersJune 15, 2025 | seekingalpha.comAssenagon Asset Management S.A. Sells 391,322 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK)June 15, 2025 | marketbeat.comCantor Fitzgerald Predicts STOK FY2026 EarningsJune 10, 2025 | marketbeat.comKangaroo Care Awareness Day celebrated at Stoke Mandeville HospitalJune 10, 2025 | msn.comJong Oranje and Stoke City star is open to transfer: “Of course, I have my ambitions”June 10, 2025 | sports.yahoo.comStoke City confirm next stage of major badge consultationJune 10, 2025 | msn.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK)June 10, 2025 | marketbeat.comStoke Therapeutics, Inc. (NASDAQ:STOK) Shares Sold by Two Sigma Investments LPJune 9, 2025 | marketbeat.comJane Street Group LLC Sells 318,465 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK)June 8, 2025 | marketbeat.comFive hours of 'thundery showers' to rock Stoke-on-Trent todayJune 7, 2025 | msn.comCelebrations as Stoke-on-Trent turns 100 years oldJune 7, 2025 | bbc.comBJon Walters opens up on Sorba Thomas transfer tussle as Stoke City make first moveJune 7, 2025 | msn.comMillennium Management LLC Increases Position in Stoke Therapeutics, Inc. (NASDAQ:STOK)June 7, 2025 | marketbeat.comBarry Ticho Sells 1,745 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK) StockJune 5, 2025 | marketbeat.comStoke Therapeutics, Inc. (NASDAQ:STOK) Insider Barry Ticho Sells 6,471 SharesJune 5, 2025 | marketbeat.comStoke Therapeutics, Inc. (NASDAQ:STOK) Insider Barry Ticho Sells 1,745 SharesJune 5, 2025 | insidertrades.comStoke Therapeutics, Inc. (NASDAQ:STOK) Receives Consensus Recommendation of "Buy" from AnalystsJune 5, 2025 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Trading 10.3% Higher - Here's WhyJune 4, 2025 | marketbeat.comBNP Paribas Financial Markets Trims Holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK)June 4, 2025 | marketbeat.comVoloridge Investment Management LLC Sells 36,261 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK)May 31, 2025 | marketbeat.comStoke Therapeutics to Present at the Jefferies Global Healthcare ConferenceMay 29, 2025 | businesswire.comD. E. Shaw & Co. Inc. Sells 143,203 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK)May 29, 2025 | marketbeat.comToronto Dominion Bank Invests $35 Million in Stoke Therapeutics, Inc. (NASDAQ:STOK)May 28, 2025 | marketbeat.comDeutsche Bank AG Reduces Holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK)May 22, 2025 | marketbeat.comToronto Dominion Bank Acquires New Position in Stoke Therapeutics, Inc. (NASDAQ:STOK)May 21, 2025 | marketbeat.comTang Capital Management LLC Buys Shares of 300,000 Stoke Therapeutics, Inc. (NASDAQ:STOK)May 20, 2025 | marketbeat.comChardan Capital Has Strong Forecast for STOK FY2025 EarningsMay 20, 2025 | marketbeat.comRTW Investments LP Has $56.51 Million Holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK)May 18, 2025 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Upgraded to Strong-Buy at Cantor FitzgeraldMay 17, 2025 | marketbeat.comMPM Bioimpact LLC Has $7.57 Million Stake in Stoke Therapeutics, Inc. (NASDAQ:STOK)May 16, 2025 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Shares Gap Up Following Earnings BeatMay 15, 2025 | marketbeat.comStoke Therapeutics, Inc. (NASDAQ:STOK) Shares Purchased by Dimensional Fund Advisors LPMay 13, 2025 | marketbeat.comGranahan Investment Management LLC Trims Stake in Stoke Therapeutics, Inc. (NASDAQ:STOK)May 12, 2025 | marketbeat.comStoke Therapeutics, Inc. (NASDAQ:STOK) Receives Consensus Rating of "Buy" from BrokeragesMay 12, 2025 | marketbeat.comDAFNA Capital Management LLC Has $1.89 Million Stock Position in Stoke Therapeutics, Inc. (NASDAQ:STOK)May 10, 2025 | marketbeat.comBaker BROS. Advisors LP Increases Stock Position in Stoke Therapeutics, Inc. (NASDAQ:STOK)May 6, 2025 | marketbeat.com291,795 Shares in Stoke Therapeutics, Inc. (NASDAQ:STOK) Acquired by Schonfeld Strategic Advisors LLCMay 6, 2025 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Stock Price Down 4.4% - Here's WhyApril 30, 2025 | marketbeat.comStoke Therapeutics (STOK) Projected to Post Quarterly Earnings on MondayApril 30, 2025 | marketbeat.comRenaissance Technologies LLC Invests $1.42 Million in Stoke Therapeutics, Inc. (NASDAQ:STOK)April 30, 2025 | marketbeat.comMarshall Wace LLP Sells 719,301 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK)April 24, 2025 | marketbeat.comFY2029 Earnings Estimate for STOK Issued By Leerink PartnrsApril 18, 2025 | marketbeat.com Get Stoke Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for STOK and its competitors with MarketBeat's FREE daily newsletter. Email Address STOK Media Mentions By Week STOK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STOK News Sentiment▼0.430.90▲Average Medical News Sentiment STOK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STOK Articles This Week▼75▲STOK Articles Average Week Get Stoke Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for STOK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MIRM News AMRX News IBRX News XENE News BHC News APLS News ARWR News TWST News VCEL News KNSA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:STOK) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMost Americans have no idea this plan exists...A Dollar Crash Is Coming - Here's When It Could Happen Already in 2025, the U.S. dollar has lost more value...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stoke Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stoke Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
